Japan’s Taisho declines at home but grows overseas

17 May 2021 - Deborah Wilkes

Premium

Taisho Pharmaceutical’s Self-Medication division recorded mixed results in the 12 months ended 31 March 2021, with sales in its home market of Japan dropping by a tenth but overseas sales increasing by a third.

Click tags below for more information on topics:

Taisho

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: